Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas — Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards…
Alpha Cognition Inc., a biopharmaceutical company based in Vancouver, British Columbia and Grapevine, Texas, has announced that its Compensation Committee granted inducement awards to a new non-executive employee on October 1, 2026. The employee received nonstatutory stock options to purchase 6,000 shares of the company's common stock.
This grant is part of the Company's 2026 Inducement Grant Plan, which is exclusively used to award equity to individuals who were not previously employees of the company. The Compensation Committee approved the stock options as an inducement to attract the new employee to join the Company, in compliance with Nasdaq Listing Rule 5635(c)(4).
Brief written by urgent.news from Financial Post's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
